Apr 16, 2025
1:3
For every 3 shares held, investors received 1. The price per share adjusted from $5.32 to $1.77.
The split itself did not change the total investment value.
Cara Therapeutics, Inc. (CARA) trades on the NASDAQ Global Market in the Biotechnology industry.
Cara Therapeutics, Inc. company overviewThe latest split shown was on April 16, 2025. It was a 1-for-3 reverse split, so shareholders received 1 share for every 3 they held.
This history records 2 reverse splits between December 31, 2024 and April 16, 2025.